Global X MSCI Greece ETF
GREK · ETF
About GREK
- Issuer
- Global X
- Tracks
- MSCI All Greece Select 25-50
- Expense ratio
- 0.56%
- Assets under management
- $339.14M
- Inception
- Dec 7, 2011
- Asset class
- Equity
- Website
- globalxetfs.com
GREK key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 40.69K
- Volume
- 95.07K
- Open price
- $77.45
- High today
- $77.92
- Low today
- $76.79
- 52 Week high
- $87.68
- 52 Week low
- $60.53
Global X MSCI Greece ETF (GREK) at a glance
Global X MSCI Greece ETF (GREK) last traded at $77.34, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Today the fund has traded between $76.79 and $77.92. The current price is 0.7% above the day's low and 0.7% below its high.
Volume so far is 95.07K shares, above the average of 40.69K shares a day.
Over the past year Global X MSCI Greece ETF has ranged from $60.53 to $87.68, and now sits 62% of the way up that range.
GREK news
- Piero Cingari
- Piero Cingari
Wall Street Got Smoked By These 20 Stock Markets In 2025
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.